Compare CGTX & ESGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CGTX | ESGL |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.5M | 131.8M |
| IPO Year | 2021 | N/A |
| Metric | CGTX | ESGL |
|---|---|---|
| Price | $1.14 | $3.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | ★ 624.0K | 5.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $1.63 |
| 52 Week High | $3.83 | $4.32 |
| Indicator | CGTX | ESGL |
|---|---|---|
| Relative Strength Index (RSI) | 52.08 | 43.20 |
| Support Level | $1.00 | $2.90 |
| Resistance Level | $1.19 | $3.93 |
| Average True Range (ATR) | 0.07 | 0.18 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 80.56 | 73.33 |
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
ESGL Holdings Ltd is a waste management, treatment, and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical, and electroplating companies.